Increasing number of causalities in the hospital and increasing number of blood disorders drives the growth of Blood Preparation Market globally.
Blood Preparation Market
Global Blood Preparation Market: Overview
Blood components preparation has a rising significance in the present age. It is a process in which one unit of whole blood goes through centrifugation. It is carried out in specialized equipment known as a refrigerated centrifuge. The whole blood is a mixture of crystalloids, cellular elements, and colloids of varying the relative size, density and sediment rate which can be separated by the application of centrifugal force.
Global Blood Preparation Market: Segmentation
The global blood preparation market is segmented into its product type, blood thinning agents, and geography. On the basis of product type, the market is divided into blood components, whole blood, and blood derivatives. Blood components further include packed red cells, whole blood components, frozen plasma, leukocyte reduced red blood cells and platelet concentrate. Whole blood includes granulocytes, red cells, platelets, and plasma. Based on blood thinning agents, the market is segregated into fibrinolytic, platelet aggregation inhibitor and anticoagulants. The fibrinolytic is further classified into urokinase, tissue plasminogen activator and streptokinase. The platelet aggregation inhibitor is divided into ADP antagonists, glycoprotein Inhibitors, phosphodiesterase Inhibitors and COX Inhibitors. The anticoagulants include direct thrombin inhibitors, heparins, direct factor Xa inhibitors and vitamin K antagonists. Diversification on the basis of the region is seen into North America, Asia-Pacific, Europe, Latin America and the Middle East and Africa.
Global Blood Preparation Market: Growth Factors
The blood preparation market is a growing market owing to factors such as increasing number of causalities in the hospital, increasing number of blood disorders and increasing need for blood during surgical procedures. Also, developments made in digital technology, use of advanced instruments and rising demand for specific blood constituents and source plasma are expected to boost the growth in the market. However, the growth may be restrained due to a single major factor which is risks involved in blood transfusion. Blood transfusion involves a high risk of transmission of diseases such as viral hemorrhagic fever, HIV and Hepatitis B, thereby limiting its use for serious cases.
Global Blood Preparation Market: Regional Analysis
The largest share in the blood preparation market is held by North America and major growth can especially be seen in the U.S. This can be attributed to reasons such as an ultra-modern healthcare infrastructure, use of hi-technology for treatment purposes and strict control practiced by the FDA on the entire process of blood transfusion right from collection, preparation, and storage. Also, for favorable reimbursements for blood components, various other federal agencies are striving for health insurance portability standards to come into effect. Asia Pacific is another major region showing a robust growth. Some of the major factors contributing to the growth in this region include rapid technological advancement and continual advancements made in the healthcare sector. Major countries showing growth in Asia Pacific include China, India, Japan and Australia. Also, a significant market share is contributed by regions such as Europe, Latin America and the Middle East and Africa.
Global Blood Preparation Market: Competitive Players
Some of the major companies in the blood preparation market are AstraZeneca, Pfizer, Bristol-Myers, Celgene, GlaxoSmithKline, Shandong East Chemical, Sanofi-Aventis, Leo Pharma and Baxter Healthcare.
Global Blood Preparation Market: Regional Segment Analysis
What Reports Provides